SecurityHSIC / Henry Schein, Inc.
InstitutionBridgewater Associates, LP
ManagerRay Dalio, Bob Prince
Shares7,635
Value $ 555,000
Related 806407AB8 / Henry Schein, Inc. Common

Bridgewater Associates, LP reports 45.39% decrease in ownership of HSIC / Henry Schein, Inc.

August 13, 2018 - Bridgewater Associates, LP has filed a 13F-HR form disclosing ownership of 7,635 shares of Henry Schein, Inc. (NASDAQ:HSIC) with total holdings valued at $555,000 USD as of June 30, 2018. Bridgewater Associates, LP had filed a previous 13F-HR on May 15, 2018 disclosing 13,980 shares of Henry Schein, Inc. at a value of $940,000 USD. This represents a change in shares of -45.39 percent and a change in value of -40.96 percent during the quarter.

Other investors with positions similar to Bridgewater Associates, LP include Mainstreet Investment Advisors Llc, Country Club Trust Company, n.a., PacWest Financial Management Inc, Tiverton Asset Management Llc, Laurel Grove Capital, LLC, and QS Investors, LLC.

Henry Schein, Inc. has declared a standard industrial code (sic) of 5047 which is the "Medical, Dental, and Hospital Equipment and Supplies" industry. Bridgewater Associates, LP's top industries are "Printing, Publishing, And Allied Industries" (sic 27), "Rubber And Miscellaneous Plastics Products" (sic 30), and "Stone, Clay, Glass, And Concrete Products" (sic 32).

Bridgewater Associates, LP reports 45.39% decrease in  ownership of HSIC / Henry Schein, Inc.

13F Filings

The Security, Class, and CUSIP columns in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names and cusips.

In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Effective
Date
Form Security Class CUSIP Share
Price
Shares Change
(%)
Value
(x1000)
Change
(%)
Cost
(x1000)
Profit
(x1000)
Return
(%)
2018-06-30 13F-HR SCHEIN HENRY COM 806407102 69.97 7,635 -45.39 555 -40.96 -444 59 6.27
2018-03-31 13F-HR SCHEIN HENRY COM 806407102 13,980 940 940 0
2016-09-30 13F-HR SCHEIN HENRY COM 806407102 0 -100.00 0 -100.00 -407 0
2016-06-30 13F-HR SCHEIN HENRY COM 806407102 2,300 0.00 407 407 0
2015-12-31 13F-HR SCHEIN HENRY COM 806407102 0 -100.00 0 -100.00 -960 0
2015-09-30 13F-HR SCHEIN HENRY COM 806407102 7,235 0.00 960 960 0
2014-12-31 13F-HR SCHEIN HENRY COM 806407102 0 -100.00 0 -100.00 -262 0
2014-09-30 13F-HR SCHEIN HENRY COM 806407102 2,250 262

Related SEC Filings

HSIC / Henry Schein, Inc. / PRICE T ROWE ASSOCIATES INC /MD/ - 3G/A (Passive Investment)

2018-02-14 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 21) HENRY SCHEIN INC (Name of Issuer) COMMON STOCK (Title of Class of Securities) 806407102 (CUSIP NUMBER) December 31, 2017 (Date of Event which Requires Filing of Statement) Check the appropriate box to designate the Rule pursuant to which this Schedule is filed: [x] Rule 13d - 1(b) Rule 13d - 1(c) Rule 13d - 1(d) 1.

HSIC / Henry Schein, Inc. / PRICE T ROWE ASSOCIATES INC /MD/ - 3G/A (Passive Investment)

2018-02-14 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 21) HENRY SCHEIN INC (Name of Issuer) COMMON STOCK (Title of Class of Securities) 806407102 (CUSIP NUMBER) December 31, 2017 (Date of Event which Requires Filing of Statement) Check the appropriate box to designate the Rule pursuant to which this Schedule is filed: [x] Rule 13d - 1(b) Rule 13d - 1(c) Rule 13d - 1(d) 1.

HSIC / Henry Schein, Inc. / GENERATION INVESTMENT MANAGEMENT LLP - 13G/A (Passive Investment)

2018-02-15 sec.gov
  UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549   SCHEDULE 13G/A    Under the Securities Exchange Act of 1934 (Amendment No. 1)*    Henry Schein, Inc. (Name of Issuer)     Common Stock (Title of Class of Securities)     806407102 (CUSIP Number)     December 31, 2017 (Date of Event Which Requires Filing of this Statement)     Check the appropriate box to designate the rule pursuant to which this Schedule is filed:   o Rule 13d-1(b) x Rule 13d-1(c) o Rule 13d-1(d)     *The

HSIC / Henry Schein, Inc. / GENERATION INVESTMENT MANAGEMENT LLP - 13G/A (Passive Investment)

2018-02-15 sec.gov
  UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549   SCHEDULE 13G/A    Under the Securities Exchange Act of 1934 (Amendment No. 1)*    Henry Schein, Inc. (Name of Issuer)     Common Stock (Title of Class of Securities)     806407102 (CUSIP Number)     December 31, 2017 (Date of Event Which Requires Filing of this Statement)     Check the appropriate box to designate the rule pursuant to which this Schedule is filed:   o Rule 13d-1(b) x Rule 13d-1(c) o Rule 13d-1(d)     *The

HSIC / Henry Schein, Inc. / FMR LLC / Fidelity - 3G/A (Passive Investment)

2018-02-13 sec.gov
SCHEDULE 13G Amendment No. 5 HENRY SCHEIN INC COMMON STOCK Cusip #806407102 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [x] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) Cusip #806407102 Item 1: Reporting Person - FMR LLC Item 2: (a) [ ] (b) [ ] Item 4: Delaware Item 5: 462,804 Item 6: 0 Item 7: 5,914,144 Item 8: 0 Item 9: 5,914,144 Item 11: 3.768% Item 12: HC Cusip #806407102 Item 1: Reporting Person - Abigail P.

Related News Stories

Can Abbott's (ABT) Steady Overall Growth Aid Q3 Earnings?

3h zacks
Abbott Laboratories (ABT - Free Report) is slated to report third-quarter 2018 results before the market opens on Oct 17. Last reported quarter, the company’s earnings per share exceeded the Zacks Consensus Estimate by 2.8%. Moreover, Abbott delivered positive surprises in the trailing four quarters, the average beat being 1.86%. (9-0)

Here's Why You Should Invest in Henry Schein (HSIC) Stock

2018-10-05 zacks
Henry Schein, Inc. (HSIC - Free Report) has been gaining investors’ confidence on consistently strong results. Over the past three months, the company’s share price has outperformed its industry. The stock has gained 15.1% compared with the industry’s 4.5% rise and the S&P 500’s 5.9% gain. (7-0)

HSIC or MMSI: Which Is the Better Value Stock Right Now?

2018-10-02 zacks
Investors looking for stocks in the Medical - Dental Supplies sector might want to consider either Henry Schein (HSIC - Free Report) or Merit Medical (MMSI - Free Report) . But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find out. (2-0)

Roche Gets FDA Approval for New Formulation of Asthma Drug

2018-10-01 zacks
Roche Holding AG (RHHBY - Free Report) announced that the FDA has approved expansion prefilled syringe formulation of its asthma drug, Xolair(omalizumab). Xolair is approved for use in a 75 mg/0.5 mL and 150 mg/1 mL single-dose PFS formulation for both the approved indications of the drug - allergic asthma and chronic idiopathic urticaria (chronic hives without a known cause). Xolair is currently available in a 150 mg single-dose vial with lyophilized, sterile powder for reconstitution. (10-0)

Henry Schein's 3 Investments to Fortify Dental Implant Arm

2018-10-01 zacks
In a bid to strengthen its foothold in the high-potential dental market, Henry Schein (HSIC - Free Report) is currently focusing on new strategic developments within that niche space. Last week, the company made three new acquisitions to advance its dental implant business. (3-0)



CUSIP: 806407102